DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Hattenbach LO, Friedrich Arndt C, Lerche R. et al.
Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of low-dose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion.
Retina 2009;
29: 932-940
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.